Leonard Udel Lacefield III

Leonard Lacefield practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Leonard Lacefield's NPI, 1447590088, was assigned on February 19, 2013. Leonard Lacefield holds Oklahoma license 5651.

Leonard Lacefield's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Leonard Lacefield also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Leonard Lacefield's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Utica Park Clinic. Dmand AI also links Leonard Lacefield to 4 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Leonard Lacefield practices. Vendor and product names are available with a free account.

Internal medicine is Leonard Lacefield's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Leonard Lacefield's licenses on file in 4 states: Oklahoma, Ohio, Oregon and Washington.

CMS data shows 554 Medicare services from Leonard Lacefield across 3 procedure codes in 2024, for 374 Medicare patients. Medicare paid $57,496 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 374 Medicare patients who saw Leonard Lacefield in 2024. The largest group is 75 to 84, with 145 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Leonard Lacefield's median patient age at 68, with 58% women.

In 2019, Leonard Lacefield wrote 77 Medicare Part D claims. They cover 5 drugs, with $625 in total drug cost. In 2018, CMS named 188 claims across 12 drugs.

CMS Open Payments shows 13 general payments to Leonard Lacefield from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Mirum Pharmaceuticals, Inc. paid the most, $150.